Loading
Latest filing published 26 Oct 2023 for ImmunoPrecise Antibodies Ltd., €9,659.
No signal scores available.
Barry Alan Springer discloses dealings in ImmunoPrecise Antibodies Ltd. to SEDI. We count 2 filings; the first trade dates from 1 September 2023 and the latest from 25 October 2023.
No open-market sale appears; the market trades are 1 purchase worth €9,659. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 26 October 2023 with an open-market purchase (€9,659) in ImmunoPrecise Antibodies Ltd. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations